Concerns About Eye Toxicity Could Limit GSK’s Myeloma Drug Potential

US FDA Flags Safety Ahead Of Meeting

 
• By Andrew McConaghie
  
GSK_HQ
2020 marks GSK's return to the oncology field, including the highly competitive multiple myeloma market
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip